CompletedNot Applicable

Effectiveness of Enhanced Terminal Room Disinfection to Prevent Healthcare-associated Infections (HAIs)

United States21,395 participantsStarted 2012-04

Plain-language summary

Enhanced terminal room disinfection is a novel, promising, but still unproven strategy for the prevention of healthcare-associated infections (HAIs) due to selected multidrug-resistant (MDR) bacterial pathogens. The investigators will perform a large prospective, multicenter study enhanced terminal room disinfection to 1) determine the efficacy and feasibility of enhanced terminal room disinfection strategies to prevent HAIs and 2) determine the impact of environmental contamination on acquisition of MDR-pathogens among hospitalized patients.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Any seed room (ie., room from which a patient with one of the target organisms has been transferred or discharged) Exclusion Criteria: * None, intervention is at level of the room, not the patient * Patient outcomes will be excluded if clinical cultures are obtained within 48 hours of admission to the room of interest.

What they're measuring

Clinical incidence rate of four target organisms among patients admitted to a study room

Timeframe: 90 days

Clinical incidence rate of C. difficile among patients admitted to a study room

Timeframe: 28 days

Trial details

NCT IDNCT01579370

SponsorDuke University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2014-07

View on ClinicalTrials.gov More Multidrug Resistant Organisms trials